Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N S Oates

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Science (London, England : 1979)|January 1, 1980
The effect of mineralocorticoid administration on urine free dopamine in manN S Oates, C M Perkins, M R Lee
Clinical Pharmacology and Therapeutics|July 1, 1982
Genetic polymorphism of phenformin 4-hydroxylationN S Oates, R R Shah, J R Idle, et al.
Clinical Science (London, England : 1979)|March 1, 1979
Plasma and urine dopamine in man given sodium chloride in the dietN S Oates, S G Ball, C M Perkins, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Influence of oxidation polymorphism on phenformin kinetics and dynamicsN S Oates, R R Shah, J R Idle, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in GhanaiansN M Woolhouse, M Eichelbaum, N S Oates, et al.
Journal of Medical Genetics|October 1, 1985
The genetic control of phenformin 4-hydroxylationR R Shah, D A Evans, N S Oates, et al.
British Journal of Pharmacology|November 1, 1984
Genetic heterogeneity of histamine H2-receptors in the mouse vas deferensJ A Calvete, J L Donegan, R J Hayes, et al.
British Medical Journal (Clinical Research Ed.)|January 30, 1982
Impaired oxidation of debrisoquine in patients with perhexiline neuropathyR R Shah, N S Oates, J R Idle, et al.
Gut|October 1, 1984
Impaired oxidation of debrisoquine in patients with perhexiline liver injuryM Y Morgan, R Reshef, R R Shah, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1984
Oxidation phenotyping in alcoholics with liver disease of varying severityP L Lanthier, R Reshef, R R Shah, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Science (London, England : 1979)|January 1, 1980
The effect of mineralocorticoid administration on urine free dopamine in manN S Oates, C M Perkins, M R Lee
Clinical Pharmacology and Therapeutics|July 1, 1982
Genetic polymorphism of phenformin 4-hydroxylationN S Oates, R R Shah, J R Idle, et al.
Clinical Science (London, England : 1979)|March 1, 1979
Plasma and urine dopamine in man given sodium chloride in the dietN S Oates, S G Ball, C M Perkins, et al.
Clinical Pharmacology and Therapeutics|December 1, 1983
Influence of oxidation polymorphism on phenformin kinetics and dynamicsN S Oates, R R Shah, J R Idle, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in GhanaiansN M Woolhouse, M Eichelbaum, N S Oates, et al.
Journal of Medical Genetics|October 1, 1985
The genetic control of phenformin 4-hydroxylationR R Shah, D A Evans, N S Oates, et al.
British Journal of Pharmacology|November 1, 1984
Genetic heterogeneity of histamine H2-receptors in the mouse vas deferensJ A Calvete, J L Donegan, R J Hayes, et al.
British Medical Journal (Clinical Research Ed.)|January 30, 1982
Impaired oxidation of debrisoquine in patients with perhexiline neuropathyR R Shah, N S Oates, J R Idle, et al.
Gut|October 1, 1984
Impaired oxidation of debrisoquine in patients with perhexiline liver injuryM Y Morgan, R Reshef, R R Shah, et al.
Alcoholism, Clinical and Experimental Research|September 1, 1984
Oxidation phenotyping in alcoholics with liver disease of varying severityP L Lanthier, R Reshef, R R Shah, et al.
Pageof 2